sickness/sick all the day; sweats; fever; muscle aches; body aches; headaches; this is a spontaneous report received from a contactable reporter (consumer) from the regulatory authority. the reporter is the patient. regulatory number: gb-mhra-webcovid-202202151922305450-lljc2 (ra). other case identifier: gb-mhra-adr 26608253 (ra). an 18 year-old female patient received bnt162b2 (comirnaty), administration date 14feb2022 (batch/lot number: unknown) as dose 2, single for covid-19 immunisation. relevant medical history included: "suspected covid-19", start date: 04feb2022 (ongoing). the patient's concomitant medications were not reported. vaccination history included: covid-19 vaccine (dose 1, manufacturer unknown), for covid-19 immunisation. the following information was reported: pyrexia (medically significant) with onset feb2022, outcome "unknown", described as "fever"; illness (medically significant) with onset 15feb2022, outcome "not recovered", described as "sickness/sick all the day"; myalgia (medically significant) with onset feb2022, outcome "unknown", described as "muscle aches"; pain (medically significant) with onset feb2022, outcome "unknown", described as "body aches"; headache (medically significant) with onset feb2022, outcome "unknown", described as "headaches"; hyperhidrosis (medically significant) with onset 15feb2022, outcome "not recovered", described as "sweats". the patient underwent the following laboratory tests and procedures: sars-cov-2 test: (11feb2022) no - negative covid-19 test. clinical course: patient had been being sick all day, had a fever, muscle and body aches, headaches, sweats. patient had not tested positive for covid-19 since having the vaccine. patient was not enrolled in clinical trial. no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected